Varian Medical Systems (VAR)
Add to Watchlists Create an AlertVarian Medical Systems R&D Expense Quarterly:
50.90M for Dec. 31, 2012Varian Medical Systems Historical R&D Expense Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 50.90M |
| Dec. 31, 2012 | 47.12M |
| Sept. 30, 2012 | 45.97M |
| June 30, 2012 | 48.94M |
| March 31, 2012 | 47.07M |
| Dec. 31, 2011 | 43.76M |
| Sept. 30, 2011 | 43.92M |
| June 30, 2011 | 44.43M |
| March 31, 2011 | 43.87M |
| Dec. 31, 2010 | 38.50M |
| Sept. 30, 2010 | 40.57M |
| June 30, 2010 | 38.87M |
| March 31, 2010 | 38.92M |
| Dec. 31, 2009 | 38.39M |
| Sept. 30, 2009 | 38.09M |
| June 30, 2009 | 35.32M |
| March 31, 2009 | 36.98M |
| Dec. 31, 2008 | 36.98M |
| Sept. 30, 2008 | 39.13M |
| June 30, 2008 | 35.65M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
VAR R&D Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Cyberonics | 10.24M |
| Accuray | 15.70M |
| Cantel Medical Corporation | 2.183M |
VAR R&D Expense Quarterly Rankings
| Overall |
97th percentile 199 of 8006 |
| Sector |
92nd percentile 49 of 686 in Healthcare |
| Industry |
91st percentile 6 of 74 in Medical Instruments & Supplies |
VAR R&D Expense Quarterly Range, Past 5 Years
| Minimum | 35.33M | Jun 2009 |
| Maximum | 50.90M | Mar 2013 |
| Average | 41.67M |